Advertisement

Craniopharyngioma: Current Classification, Management, and Future Directions

  • Zohreh Habibi
  • Deya Abu Reesh
  • James T. RutkaEmail author
Chapter

Abstract

Craniopharyngioma is one of the most challenging brain tumors, located in sellar/suprasellar region in close proximity to the optic apparatus and hypothalamus. Although histologically low grade, the tumor can be locally aggressive and serve as a source of considerable morbidity due to compression and/or adherence to nearby structures. Due to its unpredictable natural history and long-term sequelae of various treatments, the ideal management of craniopharyngioma has been constantly debated over several generations of neurosurgeons. Many clinical series have advocated for gross total resection (GTR) to reduce the risk of tumor recurrence, while craniopharyngiomas are considered unresectable lesions by other authors and a recommendation for a more conservative neurosurgical approach followed by radiation therapy or intracystic treatment is given. The ongoing debate regarding the use of “aggressive” or “less invasive” surgical approaches has at least the benefit of suggesting that treatment plans should be customized to the individual patient and tumor characteristics. In this way, the maximum, safe neurosurgical procedure can be performed while minimizing untoward patient morbidity.

References

  1. 1.
    Alli S, Isik S, Rutka JT (2016) Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance. J Neurooncol 130(2):299–307CrossRefPubMedGoogle Scholar
  2. 2.
    Apps JR, Martinez-Barbera JP (2016) Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice. Neurosurg Focus 41(6):E4CrossRefPubMedGoogle Scholar
  3. 3.
    Balogun JA, Rutka JT (2015) Surgery of craniopharyngiomas in children. In: Kenning TJ, Evans JJ (eds) Craniopharyngiomas. Comprehensive diagnosis, treatment and outcome. Elsevier, New York, pp 459–477Google Scholar
  4. 4.
    Banna M (1973) Craniopharyngioma in adults. SurgNeurol 1:202–204Google Scholar
  5. 5.
    Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83(5):781–785CrossRefPubMedGoogle Scholar
  6. 6.
    Barkhoudarian G, Laws ER (2013) Craniopharyngioma: history. Pituitary 16:1–8CrossRefPubMedGoogle Scholar
  7. 7.
    Bartels S, Adisa A, Aladelusi T, Lemound J, Stucki-Koch A, Hussein S, Kreipe H, Hartmann C, Lehmann U, Hussein K (2018) Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas differences in mutation profiles in epithelial-derived oropharyngeal neoplasms. Virchows Arch 472(6):1055–1059.  https://doi.org/10.1007/s00428-018-2323-3 CrossRefPubMedGoogle Scholar
  8. 8.
    Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) 3:39CrossRefGoogle Scholar
  9. 9.
    Bernstein JH, Waber DP (1996) Developmental Scoring System for the Rey-Osterrieth Complex Figure. Professional manual. Psychological Assessment Resources, LutzGoogle Scholar
  10. 10.
    Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, Chintagumpala M, Kahalley LS, McAleer MF, McGovern SL, Whitehead WE, Grosshans DR (2014) Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys 90(2):354–361CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Brastianos PK, Santagata S (2016) Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol 174(4):R139–R144CrossRefPubMedGoogle Scholar
  12. 12.
    Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46:161–165CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bremer AM, Nguyen TQ, Balsys R (1984) Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. I Ncuroomol 2:47–51Google Scholar
  14. 14.
    Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–551CrossRefPubMedGoogle Scholar
  15. 15.
    Carmel PW, Antunes JL, Chang CH (1982) Craniopharyngiomas in children. Neurosurgery 11:382–389CrossRefPubMedGoogle Scholar
  16. 16.
    Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL (2001) Memory deficits among children with craniopharyngiomas. Neurosurgery 49(5):1053–1057PubMedGoogle Scholar
  17. 17.
    Cavalheiro S, Di Rocco C, Valenzuela S, Dastoli PA, Tamburrini G, Massimi L, Nicacio JM, Faquini IV, Ierardi DF, Silva NS, Pettorini BL, Toledo SR (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-α: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E1CrossRefGoogle Scholar
  18. 18.
    Chen M, Zheng SH, Yang M, Chen ZH, Li ST (2018) The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neurooncol 138(1):113–122.  https://doi.org/10.1007/s11060-018-2776-x. CrossRefPubMedGoogle Scholar
  19. 19.
    Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J (2013) Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro Oncol 15(6):767–774CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Cook DJ, Rutka JT (2009) Craniopharyngiomas: neurosurgical management. In: Hanna YE, DeMonte F (eds) Comprehensive management of skull base tumors. Informa Healthcare, New York, pp 573–581Google Scholar
  21. 21.
    Coy S, Rashid R, Lin JR, Du Z, Donson AM, Hankinson TC, Foreman NK, Manley PE, Kieran MW, Reardon DA, Sorger PK, Santagata S (2018) Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma. Neuro Oncol 20(8):1101–1112.  https://doi.org/10.1093/neuonc/noy035 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Crotty TB, Scheithauer BW, Young WF Jr, Davis DH, Shaw EG, Miller GM, Burger PC (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214CrossRefPubMedGoogle Scholar
  23. 23.
    Crowley RK (2011) Hypothalamic disease in craniopharyngioma patients [MD Thesis]. Royal College of Surgeons in Ireland, DublinGoogle Scholar
  24. 24.
    Defoort-Dhellemmes S, Moritz F, Bouacha I, Vinchon M (2006) Craniopharyngioma: ophthalmological aspects at diagnosis. J Pediatr Endocrinol Metab JPEM 19(Suppl 1):321–324PubMedGoogle Scholar
  25. 25.
    Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, Dhellemmes P (2008) Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery 63:1045–1053CrossRefPubMedGoogle Scholar
  26. 26.
    Desai KI, Nadkarni TD, Muzumdar DP, Goel AH (2002) Surgical management of colloid cyst of the third ventricle—a study of 105 cases. Surg Neurol 57:295–302CrossRefPubMedGoogle Scholar
  27. 27.
    Drimtzias E, Falzon K, Picton S, Jeeva I, Guy D, Nelson O, Simmons I (2014) The ophthalmic natural history of paediatric craniopharyngioma: a long-term review. J Neurooncol 120(3):651–656CrossRefPubMedGoogle Scholar
  28. 28.
    Elliott RE, Sands SA, Strom RG, Wisoff JH (2010) Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurg Focus 28:E2CrossRefPubMedGoogle Scholar
  29. 29.
    Erdheim J (1904) Uber hypophysenganggeschwwuste und hirncholesteatome. Gerold, WienGoogle Scholar
  30. 30.
    Fitzek MM, Linggood RM, Adams J, Munzenrider JE (2006) Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys 64:1348–1354CrossRefPubMedGoogle Scholar
  31. 31.
    Fjalldal S, Follin C, Svärd D, Rylander L, Gabery S, Petersen Å, Van Westen D, Sundgren P, Bjorkman-Burtscher I, Lätt J, Ekman B, Johanson A, Erfurth EM (2018) Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma. Eur J Endocrinol 178(6):577–587.  https://doi.org/10.1530/EJE-18-0081 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, Osterberg K, Erfurth EM (2013) Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metabol 98(8):3253–3262CrossRefGoogle Scholar
  33. 33.
    Gerganov V, Metwali H, Samii A, Fahlbusch R, Samii M (2014) Microsurgical resection of extensive craniopharyngiomas using a frontolateral approach: operative technique and outcome. J Neurosurg 120:559–570CrossRefPubMedGoogle Scholar
  34. 34.
    Golshani KJ, Lalwani K, Delashaw JB, Selden NR (2009) Modified orbitozygomatic craniotomy for craniopharyngioma resection in children. J Neurosurg Pediatr 4:345–352CrossRefPubMedGoogle Scholar
  35. 35.
    Gong J, Zhang H, Xing S, Li C, Ma Z, Jia G, Hu W (2014) High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children. Cancer Biomark 14(4):241–251CrossRefPubMedGoogle Scholar
  36. 36.
    González Briceño L, Grill J, Bourdeaut F, Doz F, Beltrand J, Benabbad I, Brugières L, Dufour C, Valteau-Couanet D, Guerrini-Rousseau L, Aerts I, Orbach D, Alapetite C, Samara-Boustani D, Pinto G, Simon A, Touraine P, Sainte-Rose C, Zerah M, Puget S, Elie C, Polak M (2014) Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome. Horm Res Paediatr 82(6):364–371CrossRefPubMedGoogle Scholar
  37. 37.
    Graffeo CS, Perry A, Link MJ, Daniels DJ (2018) Pediatric craniopharyngiomas: a primer for the skull base surgeon. J Neurol Surg B 79(1):65–80CrossRefGoogle Scholar
  38. 38.
    Greenfield BJ, Okcu MF, Baxter PA, Chintagumpala M, Teh BS, Dauser RC, Su J, Desai SS, Paulino AC (2015) Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol 114(2):224–229CrossRefPubMedGoogle Scholar
  39. 39.
    Hadad G, Bassagasteguy L, Carrau RL, Mataza JC, Kassam A, Snyderman CH, Mintz A (2006) A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope 116:1882–1886CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Halac I, Zimmerman D (2005) Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 21(8–9):640–648CrossRefPubMedGoogle Scholar
  41. 41.
    Hirsch O (1912) Die operative behandlung von hypophysistumoren: Nach endonasalen methoden. Arch Laryngol Rhinol 26:529–686Google Scholar
  42. 42.
    Hoffmann A, Bootsveld K, Gebhardt U, Daubenbuchel AM, Sterkenburg AS, Muller HL (2015) Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J Endocrinol 173(3):389–397CrossRefPubMedGoogle Scholar
  43. 43.
    Hopper N, Albanese A, Ghirardello S, Maghnie M (2006) The pre-operative endocrine assessment of craniopharyngiomas. JPEM 19(Suppl 1):325–327PubMedGoogle Scholar
  44. 44.
    Jastak S (1990) Wide range assessment of memory and learning. Adams and Sheslow, New YorkGoogle Scholar
  45. 45.
    Kaplan E, Goodglass H, Weintraub S (1983) Boston naming test. Lea & Febiger, PhiladelphiaGoogle Scholar
  46. 46.
    Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62(4):397–409CrossRefGoogle Scholar
  47. 47.
    Kassam AB, Gardner PA, Snyderman CH, Carrau RL, Mintz AH, Prevedello DM (2008) Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum. J Neurosurg 108:715–728CrossRefPubMedGoogle Scholar
  48. 48.
    Klimo P Jr, Venable GT, Boop FA, Merchant T (2015) Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment. J Neurosurg Pediatr 15:499–505CrossRefPubMedGoogle Scholar
  49. 49.
    Lafay-Cousin L, Bartels U, Raybaud C, Kulkarni AV, Guger S, Huang A, Bouffet E (2007) Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. J Neurosurg 107(4 Suppl):318–323CrossRefPubMedGoogle Scholar
  50. 50.
    Lamiman K, Wong KK, Tamrazi B, Nosrati JD, Olch A, Chang EL, Kiehna EN (2016) A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus 41(6):E15CrossRefPubMedGoogle Scholar
  51. 51.
    Leber KA, Berglöff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43–50CrossRefPubMedGoogle Scholar
  52. 52.
    Lee YY, Wong TT, Fang YT, Chang KP, Chen YW, Niu DM (2008) Comparison of hypothalamopituitary axis dysfunction of intrasellar and third ventricular craniopharyngiomas in children. Brain Dev 30(3):189–194CrossRefPubMedGoogle Scholar
  53. 53.
    Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279CrossRefPubMedGoogle Scholar
  54. 54.
    Lippens RJ, Rotteveel JJ, Otten BJ, Merx H (1998) Chemotherapy with Adriamycin@ (doxorubicin) and CCNU@ (lomustine) in four children with recurrent craniopharyngiomaEur. J Paediatr Neurol 2(5):263–268CrossRefGoogle Scholar
  55. 55.
    Liu JK, Christiano LD, Gupta G, Carmel PW (2010) Surgical nuances for removal of retrochiasmatic craniopharyngiomas via the transbasal subfrontal translamina terminalis approach. Neurosurg Focus 28:E6CrossRefPubMedGoogle Scholar
  56. 56.
    Iughetti L, Bruzzi P (2011) Obesity and craniopharyngioma. Ital J Pediatr 16(37):38CrossRefGoogle Scholar
  57. 57.
    Luu QT, Loredo LN, Archambeau JO, Yonemoto LT, Slater JM, Slater JD (2006) Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J 12:155–159PubMedGoogle Scholar
  58. 58.
    Martinez-Gutierrez JC, D’Andrea MR, Cahill DP, Santagata S, Barker FG 2nd, Brastianos PK (2016) Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. Neurosurg Focus 41(6):E2CrossRefPubMedGoogle Scholar
  59. 59.
    Miller DC (1994) Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg 21(Suppl 1):11–17CrossRefPubMedGoogle Scholar
  60. 60.
    Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S, Warrington J, Burke K, Mosleh-Shirazi A, Brada M (2007) Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 82:90–95CrossRefPubMedGoogle Scholar
  61. 61.
    Morisako H, Goto T, Goto H, Bohoun CA, Tamrakar S, Ohata K (2016) Aggressive surgery based on an anatomical subclassification of craniopharyngiomas. Neurosurg Focus 41(6):E10CrossRefPubMedGoogle Scholar
  62. 62.
    Müller HL (2016) Risk-adapted treatment and followup management in childhood-onset craniopharyngioma. Expert Rev Neurother 16(5):535–548CrossRefPubMedGoogle Scholar
  63. 63.
    Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69:193–202PubMedGoogle Scholar
  64. 64.
    Muller HL (2016) Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 23(1):81–89CrossRefPubMedGoogle Scholar
  65. 65.
    Murphy MJ, Chang SD, Gibbs IC, Le QT, Hai J, Kim D, Martin DP, Adler JR Jr (2003) Patterns of patient movement during frameless image-guided radiosurgery. Int J Radiat Oncol Biol Phys 55:1400–1408CrossRefPubMedGoogle Scholar
  66. 66.
    Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jorgensen JO, Bjerre P, Andersen M, Andersen C, Jorgensen J, Lindholm J, Laurberg P (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 104:755–763CrossRefPubMedGoogle Scholar
  67. 67.
    Pettorini BL, Inzitari R, Massimi L, Tamburrini G, Caldarelli M, Fanali C, Cabras T, Messana I, Castagnola M, Di Rocco C (2010) The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst 26(12):1779–1784CrossRefPubMedGoogle Scholar
  68. 68.
    Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E (2004) Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220–229CrossRefPubMedGoogle Scholar
  69. 69.
    Prabhu VC, Brown HG (2005) The pathogenesis of craniopharyngiomas. Childs Nerv Syst 21(8–9):622–627CrossRefPubMedGoogle Scholar
  70. 70.
    Prieto R, Pascual JM, Rosdolsky M, Barrios L (2018) Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus. World Neurosurg 110:e404–e426CrossRefPubMedGoogle Scholar
  71. 71.
    Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12PubMedGoogle Scholar
  72. 72.
    Rhoton AL Jr (2002) The sellar region. Neurosurgery 51(4 Suppl):S335–S374PubMedGoogle Scholar
  73. 73.
    Rhoton AL Jr (2001) Anatomy of the pituitary gland and sellar region. In: Thapar K, Kovacs K, Scheithauer BW, Lloyd RV (eds) Diagnosis and management of pituitary tumors. Humana Press, TotowaGoogle Scholar
  74. 74.
    Robinson AG, Verbalis JG (2003) Posterior pituitary gland. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Elsevier, Philadelphia, pp 281–329Google Scholar
  75. 75.
    Rosenfeld A, Arrington D, Miller J, Olson M, Gieseking A, Etzl M, Harel B, Schembri A, Kaplan A (2014) A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol 50(1):4–10CrossRefPubMedGoogle Scholar
  76. 76.
    Rutka JT (2002) Craniopharyngioma. J Neurosurg 97:1–2CrossRefPubMedGoogle Scholar
  77. 77.
    Rutka JT, Hoffman HJ, Drake JM, Humphreys RP (1992) Suprasellar and sellar tumors in childhood and adolescence. Neurosurg Clin N Am 3:803–820CrossRefPubMedGoogle Scholar
  78. 78.
    Schiebler TH, Schmidt W, Zilles K (1995) Anatomie. Springer, BerlinCrossRefGoogle Scholar
  79. 79.
    Sekine S, Takata T, Shibata T, Mori M, Morishita Y, Noguchi M, Uchida T, Kanai Y, Hirohashi S (2004) Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology 45:573–579CrossRefPubMedGoogle Scholar
  80. 80.
    Shi XE, Wu B, Fan T, Zhou ZQ, Zhang YL (2008) Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg 110:151–159CrossRefPubMedGoogle Scholar
  81. 81.
    Shoemaker A, Proietto J, Abuzzahab MJ, Markovic T, Malloy J, Kim DD (2017) A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity. Diabetes Obes Metab 19(8):1165–1170CrossRefPubMedGoogle Scholar
  82. 82.
    Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77(4):587–592CrossRefPubMedGoogle Scholar
  83. 83.
    Stark KL, Kaufman B, Lee BC, Primack J, Tychsen L (1999) Visual recovery after a year of craniopharyngioma-related amaurosis: report of a nine-year-old child and a review of pathophysiologic mechanisms. JAAPOS 3:366–371Google Scholar
  84. 84.
    Tomita T, McLone DG (1993) Radical resections of childhood craniopharyngiomas. Pediatr Neurosurg 19(1):6–14CrossRefPubMedGoogle Scholar
  85. 85.
    Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431CrossRefGoogle Scholar
  86. 86.
    Van Effenterre R, Boch AL (2002) Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97:3–11CrossRefPubMedGoogle Scholar
  87. 87.
    Vaquero J, Zurita M, de Oya S, Coca S, Morales C, Salas C (1999) Expression of vascular permeability factor in craniopharyngioma. J Neurosurg 91:831–834CrossRefPubMedGoogle Scholar
  88. 88.
    Veeravagu A, Lee M, Jiang B, Chang SD (2010) The role of radiosurgery in the treatment of craniopharyngiom. Neurosurg Focus 28(4):E11CrossRefPubMedGoogle Scholar
  89. 89.
    Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal betaemitting radioactive sources. Neurosurgery 40:263–270CrossRefPubMedGoogle Scholar
  90. 90.
    Wang F, Jiang J, Zhang J, Wang Q (2017) Predicting pituitary stalk position by in vivo visualization of the hypothalamo-hypophyseal tract in craniopharyngioma using diffusion tensor imaging tractography. Neurosurg Rev 41(3):841–849.  https://doi.org/10.1007/s10143-017-0933-x. CrossRefPubMedGoogle Scholar
  91. 91.
    Wechsler D (1991) WISC-III: Wechsler Intelligence Scale for children, 3rd edn. Psychological Corp, San AntonioGoogle Scholar
  92. 92.
    Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001–1010CrossRefPubMedGoogle Scholar
  93. 93.
    Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P (1990) Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73(1):3–11CrossRefPubMedGoogle Scholar
  94. 94.
    Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G (2015) Type I interferons in anticancer immunity. Nat Rev Immunol 15(7):405–414CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Zohreh Habibi
    • 1
    • 2
    • 3
  • Deya Abu Reesh
    • 1
    • 2
  • James T. Rutka
    • 2
    • 4
    Email author
  1. 1.Division of NeurosurgeryHospital for Sick ChildrenTorontoCanada
  2. 2.Department of SurgeryUniversity of TorontoTorontoCanada
  3. 3.Department of Neurosurgery, Children’s Medical CenterTehran University of Medical SciencesTehranIran
  4. 4.Division of NeurosurgeryThe Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick ChildrenTorontoCanada

Personalised recommendations